These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25000955)

  • 21. Antiviral therapy after curative resection for patients with hepatitis B-related hepatocellular carcinoma.
    Chong CC; Lai PB
    Br J Surg; 2013 May; 100(6):724-5. PubMed ID: 23475744
    [No Abstract]   [Full Text] [Related]  

  • 22. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
    Hosaka T; Suzuki F; Kobayashi M; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    Liver Int; 2010 Nov; 30(10):1461-70. PubMed ID: 20840396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma].
    Lengyel G; Fehér J
    Orv Hetil; 2010 Jul; 151(29):1177-81. PubMed ID: 20591786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence.
    Tan ZM; Sun BC
    World J Gastroenterol; 2013 Dec; 19(47):8895-901. PubMed ID: 24379613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma?
    Ridruejo E
    Expert Opin Drug Saf; 2015 Mar; 14(3):439-51. PubMed ID: 25547687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus: from diagnosis to treatment.
    Dény P; Zoulim F
    Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.
    Chong CC; Wong GL; Lai PB
    World J Gastroenterol; 2014 May; 20(20):6006-12. PubMed ID: 24876723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma.
    Teng CF; Wu HC; Su IJ; Jeng LB
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis B virus (HBV) infection and hepatocarcinogenesis].
    Pár A
    Orv Hetil; 2010 Jun; 151(26):1045-53. PubMed ID: 20558351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?
    Vezali E; Aghemo A; Lampertico P; Colombo M
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):455-64. PubMed ID: 21435968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral hepatitis B and hepatocellular carcinoma.
    Michielsen P; Ho E
    Acta Gastroenterol Belg; 2011 Mar; 74(1):4-8. PubMed ID: 21563647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B Before and After Hepatocellular Carcinoma.
    Harputluoglu M; Carr BI
    J Gastrointest Cancer; 2021 Dec; 52(4):1206-1210. PubMed ID: 34762265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial.
    Huang G; Lau WY; Wang ZG; Pan ZY; Yuan SX; Shen F; Zhou WP; Wu MC
    Ann Surg; 2015 Jan; 261(1):56-66. PubMed ID: 25072444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kuzuya T; Katano Y; Kumada T; Toyoda H; Nakano I; Hirooka Y; Itoh A; Ishigami M; Hayashi K; Honda T; Goto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1929-35. PubMed ID: 17914972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative therapy options for hepatocellular carcinoma.
    Zhong JH; Ma L; Li LQ
    Scand J Gastroenterol; 2014 Jun; 49(6):649-61. PubMed ID: 24716523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reasons to consider earlier treatment of chronic HBV infections.
    Zoulim F; Mason WS
    Gut; 2012 Mar; 61(3):333-6. PubMed ID: 22147510
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of therapy on the long-term outcome of chronic hepatitis B.
    Liaw YF
    Clin Liver Dis; 2013 Aug; 17(3):413-23. PubMed ID: 23905813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.